Context Therapeutics Inc (CNTX)
1.50
-0.13
(-7.98%)
USD |
NASDAQ |
Nov 21, 16:00
1.34
-0.16
(-10.67%)
After-Hours: 20:00
Context Therapeutics Enterprise Value: 27.70M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 27.70M |
| November 20, 2024 | 37.45M |
| November 19, 2024 | 38.95M |
| November 18, 2024 | 41.20M |
| November 15, 2024 | 53.20M |
| November 14, 2024 | 57.70M |
| November 13, 2024 | 62.95M |
| November 12, 2024 | 68.94M |
| November 11, 2024 | 68.20M |
| November 08, 2024 | 61.45M |
| November 07, 2024 | 71.94M |
| November 06, 2024 | 81.69M |
| November 05, 2024 | 80.94M |
| November 04, 2024 | 82.44M |
| November 01, 2024 | 85.44M |
| October 31, 2024 | 78.69M |
| October 30, 2024 | 77.94M |
| October 29, 2024 | 83.19M |
| October 28, 2024 | 87.69M |
| October 25, 2024 | 90.69M |
| October 24, 2024 | 91.44M |
| October 23, 2024 | 82.44M |
| October 22, 2024 | 65.20M |
| October 21, 2024 | 69.69M |
| October 18, 2024 | 68.20M |
| Date | Value |
|---|---|
| October 17, 2024 | 65.94M |
| October 16, 2024 | 68.94M |
| October 15, 2024 | 61.45M |
| October 14, 2024 | 64.45M |
| October 11, 2024 | 62.20M |
| October 10, 2024 | 43.45M |
| October 09, 2024 | 53.20M |
| October 08, 2024 | 54.70M |
| October 07, 2024 | 52.45M |
| October 04, 2024 | 59.20M |
| October 03, 2024 | 63.70M |
| October 02, 2024 | 56.95M |
| October 01, 2024 | 54.70M |
| September 30, 2024 | 62.20M |
| September 27, 2024 | 37.96M |
| September 26, 2024 | 37.21M |
| September 25, 2024 | 43.21M |
| September 24, 2024 | 45.46M |
| September 23, 2024 | 54.46M |
| September 20, 2024 | 67.96M |
| September 19, 2024 | 65.71M |
| September 18, 2024 | 45.46M |
| September 17, 2024 | 54.46M |
| September 16, 2024 | 54.46M |
| September 13, 2024 | 55.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-29.68M
Minimum
Dec 28 2022
154.16M
Maximum
Jun 25 2024
10.17M
Average
-8.442M
Median
Enterprise Value Benchmarks
| Collegium Pharmaceutical Inc | 1.728B |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.46M |
| Total Expenses (Quarterly) | 18.70M |
| EPS Diluted (Quarterly) | -0.22 |
| Earnings Yield | -60.67% |